Evelo Biosciences, Inc. EVLO OTC

Other OTC • Healthcare • Biotechnology • US • USD

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Evelo Biosciences, Inc. (EVLO), 포함 24 건 매수 및 24 건 매도. 내부자 매수 총액은 $3.5M 내부자 매도 총액은 $126.54K.

최근 활동이 있는 주요 내부자에는 Gill Simba, Bodmer Mark, Mchale Duncan. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — EVLO

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2023-11-08	Gill Simba	President & CEO	정보 매도	172	$0.33	$56.76	17,758
2023-11-08	Bodmer Mark	CSO, President of R&d	정보 매도	3,163	$0.33	$1.04K	25,732
2023-11-08	Mchale Duncan	Chief Medical Officer	정보 매도	3,103	$0.33	$1.02K	16,984
2023-11-08	Thorell Marella	Chief Financial Officer	정보 매도	1,811	$0.33	$597.63	22,259
2023-11-07	Gill Simba	President & CEO	옵션 행사 (매도)	1,172	-	-	15,236
2023-11-07	Bodmer Mark	CSO, President of R&d	옵션 행사 (매도)	6,625	-	-	6,625
2023-11-07	Mchale Duncan	Chief Medical Officer	옵션 행사 (매도)	6,500	-	-	6,500
2023-11-07	Thorell Marella	Chief Financial Officer	옵션 행사 (매도)	6,500	-	-	6,500
2023-11-02	Bodmer Mark	CSO, President of R&d	정보 매도	6,854	$0.33	$2.26K	22,270
2023-11-02	Mchale Duncan	Chief Medical Officer	정보 매도	6,854	$0.33	$2.26K	13,587
2023-11-02	Thorell Marella	Chief Financial Officer	정보 매도	3,999	$0.33	$1.32K	17,570
2023-11-01	Bodmer Mark	CSO, President of R&d	옵션 행사 (매도)	12,500	-	-	25,000
2023-11-01	Mchale Duncan	Chief Medical Officer	옵션 행사	12,500	-	-	20,441
2023-11-01	Thorell Marella	Chief Financial Officer	옵션 행사	12,500	-	-	21,569
2023-09-28	Gill Simba	President & CEO	정보 매도	1,996	$3.94	$7.86K	16,758
2023-09-27	Gill Simba	President & CEO	옵션 행사	15,000	-	-	18,754
2023-09-11	Bodmer Mark	CSO, President of R&d	RSU 부여	37,500	-	-	37,500
2023-09-11	Mchale Duncan	Chief Medical Officer	RSU 부여	37,500	-	-	37,500
2023-09-11	Thorell Marella	Chief Financial Officer	RSU 부여	37,500	-	-	37,500
2023-08-08	Gill Simba	President & CEO	정보 매도	342	$9.51	$3.25K	3,754
2023-08-08	Bodmer Mark	CSO, President of R&d	정보 매도	3,128	$9.51	$29.75K	16,624
2023-08-08	Mchale Duncan	Chief Medical Officer	정보 매도	3,434	$9.51	$32.66K	7,941
2023-08-08	Thorell Marella	Chief Financial Officer	정보 매도	2,004	$9.51	$19.06K	9,069
2023-08-07	Gill Simba	President & CEO	옵션 행사	1,171	-	-	4,096
2023-08-07	Bodmer Mark	CSO, President of R&d	옵션 행사 (매도)	6,625	-	-	13,250
2023-08-07	Mchale Duncan	Chief Medical Officer	옵션 행사	6,500	-	-	11,375
2023-08-07	Thorell Marella	Chief Financial Officer	옵션 행사	6,500	-	-	11,073
2023-07-11	Moore Jeffrey R.	Director	알 수 없음	-	-	-	-
2023-07-11	Moore Jeffrey R.	Director	RSU 부여	2,000	$3.38	$6.76K	2,000
2023-07-11	Reynolds Alexander C	Director	알 수 없음	-	-	-	-
2023-07-11	Reynolds Alexander C	Director	RSU 부여	2,000	$3.38	$6.76K	2,000
2023-07-11	Flagship Ventures Fund Iv General Partner Llc	10 Percent Owner	정보 매수	1,082,251	$2.31	$2.5M	1,461,795
2023-07-11	Horizon Technology Finance Corp	10 Percent Owner	처분	-	-	-	2,164,502
2023-06-08	Gill Simba	President & CEO	RSU 부여	1,000,000	$0.97	$970K	1,000,000
2023-06-08	Melas Kyriazi Theo	Director	RSU 부여	20,000	$0.11	$2.2K	20,000
2023-06-08	Mchugh Julie	Director	RSU 부여	20,000	$0.11	$2.2K	20,000
2023-06-08	Rosiello Robert L.	Director	RSU 부여	30,000	$0.11	$3.3K	30,000
2023-06-08	Gutierrez-ramos Jose-carlos	Director	RSU 부여	20,000	$0.11	$2.2K	20,000
2023-06-08	Hohneker John	Director	RSU 부여	20,000	$0.11	$2.2K	20,000
2023-06-08	Andres Juan	Director	RSU 부여	20,000	$0.11	$2.2K	20,000
2023-06-08	Mcinnes Iain B.	Director	RSU 부여	20,000	$0.11	$2.2K	20,000
2023-06-08	Williams Tonya	Director	RSU 부여	20,000	$0.11	$2.2K	20,000
2023-05-23	Bodmer Mark	CSO, President of R&d	정보 매도	22,571	$0.14	$3.2K	262,557
2023-05-08	Gill Simba	President & CEO	정보 매도	3,537	$0.13	$443.89	58,512
2023-05-08	Bodmer Mark	CSO, President of R&d	정보 매도	68,014	$0.13	$8.54K	285,128
2023-05-08	Mchale Duncan	Chief Medical Officer	정보 매도	66,730	$0.13	$8.37K	97,516
2023-05-08	Thorell Marella	Chief Financial Officer	정보 매도	38,531	$0.13	$4.84K	91,469
2023-05-07	Gill Simba	President & CEO	옵션 행사	23,437	-	-	62,049
2023-05-07	Bodmer Mark	CSO, President of R&d	옵션 행사	132,500	-	-	353,142
2023-05-07	Mchale Duncan	Chief Medical Officer	옵션 행사	130,000	-	-	164,246